deLIVER: Direct Acting Antiviral Effects on the Liver
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms deLIVER
- 22 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Apr 2017 Status changed from not yet recruiting to recruiting.
- 25 Oct 2016 New trial record